Dr Zoe Schofield


Contact via email

Early life microbiota-host interactions

I am investigating whether or not ‘good’ bacteria can shape neonatal and early life health with a focus on immune development. Using in vivo and in vitro techniques to determine if Bifidobacteria can cross the placenta and how this impacts health during pregnancy and in early life.

I completed my PhD at the Institute for Molecular Biology, The University of Queensland in 2016 under the supervision of Prof. Matthew A Cooper. My thesis focused on the role of short chain fatty acids in mesenteric ischemia reperfusion injury.

Hughes K. R., Schofield Z., Dalby M. J., Caim S., Chalklen L., Bernuzzi F., Alcon C., Le Gall G., Watson A. J. M., Hall L. J.. (2020)

The early life microbiota protects neonatal mice from pathological small intestinal epithelial cell shedding.

FASEB Journal

View Publication

Schofield Z., Croker D., Robertson A. A. B., Massey N. L., Donovan C., Tee E., Edwards D., Woodruff T. M., Halai R., Hansbro P. M., Cooper M. A.. (2018)

Characterisation of small molecule ligands 4CMTB and 2CTAP as modulators of human FFA2 receptor signalling.

Scientific reports, 8, 17819

View Publication

O'Neill I., Schofield Z., Hall L. J.. (2017)

Exploring the role of the microbiota member Bifidobacterium in modulating immune-linked diseases

Emerging Topics in Life Sciences, 1, 333-349

View Publication

Related News